Rafaela Tezza Matiola

Rafaela Tezza Matiola

Auto-generated profile, based on publicly available information

Rafaela Tezza Matiola

Laboratório de Doenças Neurometabólicas, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, Brasil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2024 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
SBSandra Bonfante
Sandra Bonfante
MNMartins Back Netto
Martins Back Netto
AJAloir Neri de Oliveira Junior
Aloir Neri de Oliveira Junior
KMKhiany Mathias
Khiany Mathias
RMRichard Simon Machado
Richard Simon Machado
FPFabricia Petronilho
Fabricia Petronilho

16 December 2023 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
ILIsabela da Silva Lemos
Isabela da Silva Lemos
CTCarolina Antunes Torres
Carolina Antunes Torres
CACarolina Giassi Alano
Carolina Giassi Alano
RMRafaela Tezza Matiola
Rafaela Tezza Matiola
RSRejane de Figueiredo Seldenreich
Rejane de Figueiredo Seldenreich
ESEmilio Luiz Streck
Emilio Luiz Streck

3 September 2025 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
ILIsabela da Silva Lemos
Isabela da Silva Lemos
RSRejane Figueiredo Seldenreich
Rejane Figueiredo Seldenreich
CACarolina Giassi Alano
Carolina Giassi Alano
LSLaura Quinsani Schmitt
Laura Quinsani Schmitt
RMRafaela Tezza Matiola
Rafaela Tezza Matiola
ESEmilio Luiz Streck
Emilio Luiz Streck

1 January 2026 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PEPauline Effting
Pauline Effting
ILIsabela S. Lemos
Isabela S. Lemos
BMBianca Z. DE Medeiros
Bianca Z. DE Medeiros
LQLaura S. Quinsani
Laura S. Quinsani
RSRejane F. Seldenreich
Rejane F. Seldenreich
ESEmilio Luiz Streck
Emilio Luiz Streck
Maple syrup urine disease (MSUD) is a rare genetic disorder characterized by a deficiency of the branched-chain α-keto acid dehydrogenase enzyme complex, resulting in the accumulation of branched-chain amino acids (BCAA) in the tissues and body fluids of patients. Metabolic decompensation plays a central role in MSUD neuropathology and is associated with memory impairment, cholinergic signaling alterations, and an oxidative stress state. Resveratrol is an antioxidant molecule, playing the role of a reactive species scavenger and modulating the gene expression of antioxidant enzymes. We aimed to evaluate the resveratrol effects on behavior and neurochemical parameters in rats subjected to an MSUD protocol. Animals were divided into four groups: Saline Control, BCAA Control, Saline Resveratrol, and BCAA + Resveratrol. After 21 days of administration, the open field habituation memory test, cholinergic system activity, and oxidative stress were assessed. Resveratrol was able to improve behavior parameters, protecting against the memory loss caused by the BCAA treatment, but had no effect on the cholinergic system. Additionally, resveratrol reduced oxidative damage and enhanced catalase activity. Herein, resveratrol can be an important adjuvant treatment for MSUD, as its antioxidant properties may be beneficial in the oxidative stress and cognitive impairment associated with the disease.

1 January 2026 in Jornal Vascular Brasileiro
Verified
Journal Article
Open access
ACAnita dos Santos Cardoso
Anita dos Santos Cardoso
YMYago Marcelino Maciel
Yago Marcelino Maciel
RNRuymara Candal Nogueira
Ruymara Candal Nogueira
RMRafaela Tezza Matiola
Rafaela Tezza Matiola
TRThais Pereira da Rosa
Thais Pereira da Rosa
BPBrunella Flores Pupo
Brunella Flores Pupo
Eagle Syndrome (ES), characterized by elongation of the styloid process (ESP), is a rare condition with diverse symptoms. Among its complications, carotid dissection is a significant outcome requiring accurate diagnosis and intervention. This study describes a case of bilateral carotid dissection associated with ES, emphasizing diagnostic challenges, management, and therapeutic approaches. Conducted under Research Ethics Committee protocol 68193123.5.0000.0119 and approval number 6.028.970, it reports on a 38-year-old woman with a 5-day history of left-sided headache, otalgia, syncope, right-hand limitation, and visual blurring. MRI revealed left carotid bulb occlusion and recent ischemic events, while angio-CT confirmed bilateral carotid dissections. After clinical management failed, an intraoral surgical approach was chosen, resulting in full neurological recovery. CT confirmed ESP, and genetic testing was negative. This case highlights the need to consider ES in atypical cervicofacial symptoms, given its underdiagnosed incidence (~4% for ESP; ~0.16% for ES), reinforcing the importance of better clinical guidelines.

3 September 2026 in Metabolic Brain Disease
Verified
Journal Article
Open access
PDF file
ILIsabela da Silva Lemos
Isabela da Silva Lemos
SDSasckia Duarte
Sasckia Duarte
MMMeline Oliveira dos Santos Morais
Meline Oliveira dos Santos Morais
CACarolina Giassi Alano
Carolina Giassi Alano
LQLaura Schmidt Quinsani
Laura Schmidt Quinsani
ESEmilio Luiz Streck
Emilio Luiz Streck
Maple Syrup Urine Disease (MSUD) is caused by a genetic mutation in the branched-chain α-ketoacid dehydrogenase complex, resulting to accumulation of branched-chain amino acids (BCAAs) that affect the central nervous system and cause neurochemical alterations and behavioral changes. In this line, full-spectrum cannabidiol (CBD)-rich oil has emerged as a potential therapeutic strategy. Therefore, this study aims to evaluate the effects of two doses of the compound full-spectrum CBD-rich oil in a BCAA-induced MSUD rat model, against behavioral, cholinergic, inflammatory, and oxidative stress parameters. For this, animals were divided into six groups: control group, CBD 3.5 mg/kg group, CBD 7.5 mg/kg group, BCAA group, BCAA + CBD 3.5 mg/kg group, and BCAA + CBD 7.5 mg/kg group. The treatment was administered over 21 days; after that, the animals were subjected to open-field and object recognition tests. Next, we extracted the cerebral cortex to analyze cholinergic function, inflammation, and oxidative stress. The results show that the open-field test revealed no differences in crossings and rearings across all groups. In object recognition test, control and CBD 3.5 groups showed improved short- and long-term memory compared to training. The CBD 7.5 and BCAA + CBD 3.5 groups showed improvement only in short-term memory. BCAA control and BCAA + 7.5 did not present differences. In the cholinergic system, BCAA control showed decreased choline acetyltransferase (ChAT) activity, which was reversed by CBD treatment at both doses. The BCAA + CBD 7.5 shows increased ChAT activity compared to control group. While acetylcholinesterase (AChE) was reduced in the CBD 7.5 groups and increased in the BCAA control group, both CBDs reversed this increase in BCAA control group. Inflammatory cytokines show increased interleukin-1β in BCAA control group, and the CBD treatment decreases its levels compared to BCAA and saline control groups. Interleukin-6 increases in BCAA control group, and CBD 3.5 reverses it. Tumoral necrosis factor-alpha was reduced in BCAA + CBD 3.5 and BCAA + CBD 7.5 compared to control and BCAA control groups. Further, under oxidative stress, BCAA control increases 2,7-dichlorofluorescein oxidation and thiobarbituric acid levels, which were reversed by CBD treatment. Sulfhydryl content was decreased in CBD 7.5, BCAA control group, BCAA + CBD 3.5, and BCAA + CBD 7.5 compared to control group. Superoxide dismutase activity increased across all groups, whereas catalase activity decreased in the BCAA control group; treatment with CBD 7.5 reversed this reduction. Overall, we conclude that full-spectrum CBD-rich oil shows therapeutic potential for MSUD, although optimal dosing and treatment duration require further investigation. Graphical abstract